Epinephrine Nasal – Talk Bio

Actionable Insights Powered by AI

ALK-Abell Acquires Epinephrine Nasal Spray for $145 Million

5 months ago talkbio0Tagged Acquisition, ALK-Abell, Dosage Forms, Epinephrine Nasal, portfolio, Spray Dosage Form

ALK-Abell, Epinephrine Nasal Spray, Acquisition, Pharmaceutical Portfolio